Role of oxidative stress in persister tolerance

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 9, 2012, Pages 4922-4926

  Wu, Yanxia ^a   Vulić, Marin ^a   Keren, Iris ^a   Lewis, Kim ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; KANAMYCIN; PARAQUAT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE;

ARTICLE; CELLS; CONTROLLED STUDY; GENE CONTROL; MACROPHAGE; MULTIDRUG RESISTANCE; MUTANT; NONHUMAN; OXIDATIVE STRESS; PERSISTER; PRIORITY JOURNAL; PROMOTER REGION; REGULON;

AMPICILLIN; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIAL TOXINS; CARRIER PROTEINS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG TOLERANCE; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; FLUOROQUINOLONES; KANAMYCIN; MICROBIAL SENSITIVITY TESTS; OXIDATIVE STRESS; PARAQUAT; REPRESSOR PROTEINS; SOS RESPONSE (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION;

EID: 84865419909     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00921-12     Document Type: Article

References (43)

1. Andrews JM. 2001. Determination of minimum inhibitory concentrations. J. Antimicrob. Chemother. 48(Suppl 1):5-16.
2. Baba T, et al. 2006. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol. Syst. Biol. 2:2006.0008.
3. Black DS, Irwin B, Moyed HS. 1994. Autoregulation of hip, an operon that affects lethality due to inhibition of peptidoglycan or DNA synthesis. J. Bacteriol. 176:4081-4091. (Pubitemid 24191293)
4. Black DS, Kelly AJ, Mardis MJ, Moyed HS. 1991. Structure and organization of hip, an operon that affects lethality due to inhibition of peptidoglycan or DNA synthesis. J. Bacteriol. 173:5732-5739.
5. Blanchard JL, Wholey WY, Conlon EM, Pomposiello PJ. 2007. Rapid changes in gene expression dynamics in response to superoxide reveal SoxRS-dependent and independent transcriptional networks. PLoS One 2:e1186. doi:10.1371/journal. pone.0001186.
6. Boaretti M, Lleo MM, Bonato B, Signoretto C, Canepari P. 2003. Involvement of rpoS in the survival of Escherichia coli in the viable but non-culturable state. Environ. Microbiol. 5:986-996. (Pubitemid 37181569)
7. Brooun A, Liu S, Lewis K. 2000. A dose-response study of antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 44:640-646. (Pubitemid 30117954)
8. Christensen SK, Pedersen K, Hansen FG, Gerdes K. 2003. Toxinantitoxin loci as stress-response-elements: ChpAK/MazF and ChpBK cleave translated RNAs and are counteracted by tmRNA. J. Mol. Biol. 332:809-819. (Pubitemid 37101369)
9. Correia FF, et al. 2006. Kinase activity of overexpressed HipA is required for growth arrest and multidrug tolerance in Escherichia coli. J. Bacteriol. 188:8360-8367. (Pubitemid 44894035)
10. Ding H, Hidalgo E, Demple B. 1996. The redox state of the [2Fe-2S] clusters in SoxR protein regulates its activity as a transcription factor. J. Biol. Chem. 271:33173-33175. (Pubitemid 27010121)
11. Dörr T, Lewis K, Vulic M. 2009. SOS response induces persistence to fluoroquinolones in Escherichia coli. PLoS Genet. 5:e1000760. doi:10.1371/journal.pgen.1000760.
12. Dörr T, Vulic M, Lewis K. 2010. Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biol. 8:e1000317. doi:10.1371/journal.pbio.1000317.
13. Evans ME, Feola DJ, Rapp RP. 1999. Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria. Ann. Pharmacother. 33:960-967. (Pubitemid 29420995)
14. Gaudu P, Weiss B. 1996. SoxR, a [2Fe-2S] transcription factor, is active only in its oxidized form. Proc. Natl. Acad. Sci. U. S. A. 93:10094-10098. (Pubitemid 26314580)
15. Gurnev PA, Ortenberg R, Dörr T, Lewis K, Bezrukov SM. 21 June 2012. Persister-promoting bacterial toxin TisB produces anion-selective pores in planar lipid bilayers. FEBS Lett. [Epub ahead of print.] doi:10.1016/j.febslet. 2012.06.021.
16. Kaldalu N, Mei R, Lewis K. 2004. Killing by ampicillin and ofloxacin induces overlapping changes in Escherichia coli transcription profile. Antimicrob. Agents Chemother. 48:890-896. (Pubitemid 38280340)
17. Keren I, Kaldalu N, Spoering A, Wang Y, Lewis K. 2004. Persister cells and tolerance to antimicrobials. FEMS Microbiol. Lett. 230:13-18. (Pubitemid 38091733)
18. Keren I, Minami S, Rubin E, Lewis K. 2011. Characterization and transcriptome analysis of Mycobacterium tuberculosis persisters. mBio 2:e00100-11. doi:10.1128/mBio.00100-11.
19. Keren I, Shah D, Spoering A, Kaldalu N, Lewis K. 2004. Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J. Bacteriol. 186:8172-8180. (Pubitemid 39603206)
20. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ. 2007. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130:797-810. (Pubitemid 47332566)
21. Korch SB, Henderson TA, Hill TM. 2003. Characterization of the hipA7 allele of Escherichia coli and evidence that high persistence is governed by (p)ppGpp synthesis. Mol. Microbiol. 50:1199-1213. (Pubitemid 37475853)
22. LaFleur MD, Kumamoto CA, Lewis K. 2006. Candida albicans biofilms produce antifungal-tolerant persister cells. Antimicrob. Agents Chemother. 50:3839-3846. (Pubitemid 44684901)
23. LaFleur MD, Qi Q, Lewis K. 2010. Patients with long-term oral carriage harbor high-persister mutants of Candida albicans. Antimicrob. Agents Chemother. 54:39-44.
24. Lewis K. 2010. Persister cells. Annu. Rev. Microbiol. 64:357-372.
25. Lewis K. 2005. Persister cells and the riddle of biofilm survival. Biochemistry (Mosc.) 70:267-274. (Pubitemid 40512338)
26. Lewis K. 2000. Programmed death in bacteria. Microbiol. Mol. Biol. Rev. 64:503-514.
27. Maisonneuve E, Shakespeare LJ, Jorgensen MG, Gerdes K. 2011. Bacterial persistence by RNA endonucleases. Proc. Natl. Acad. Sci. U. S. A. 108:13206-13211.
28. Moyed HS, Bertrand KP. 1983. hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J. Bacteriol. 155:768-775. (Pubitemid 13048115)
29. Moyed HS, Broderick SH. 1986. Molecular cloning and expression of hipA, a gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J. Bacteriol. 166:399-403. (Pubitemid 16112134)
30. Mulcahy LR, Burns JL, Lory S, Lewis K. 2010. Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis. J. Bacteriol. 192:6191-6199.
31. Nunoshiba T, DeRojas-Walker T, Tannenbaum SR, Demple B. 1995. Roles of nitric oxide in inducible resistance of Escherichia coli to activated murine macrophages. Infect. Immun. 63:794-798.
32. Pandey DP, Gerdes K. 2005. Toxin-antitoxin loci are highly abundant in free-living but lost from host-associated prokaryotes. Nucleic Acids Res. 33:966-976. (Pubitemid 41430517)
33. Pedersen K, Christensen SK, Gerdes K. 2002. Rapid induction and reversal of a bacteriostatic condition by controlled expression of toxins and antitoxins. Mol. Microbiol. 45:501-510. (Pubitemid 34779839)
34. Pomposiello PJ, Demple B. 2002. Global adjustment of microbial physiology during free radical stress. Adv. Microb. Physiol. 46:319-341. (Pubitemid 34602245)
35. Schumacher MA, et al. 2009. Molecular mechanisms of HipA-mediated multidrug tolerance and its neutralization by HipB. Science 323:396-401.
36. Shah D, Zhang Z, Khodursky AB, Kaldalu N, Kurg K, Lewis K. 2006. Persisters: a distinct physiological state of E. coli. BMC Microbiol. 6:53.
37. Spoering AL, Lewis K. 2001. Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J. Bacteriol. 183:6746-6751. (Pubitemid 33064186)
38. Touati D. 2000. Sensing and protecting against superoxide stress in Escherichia coli-how many ways are there to trigger soxRS response? Redox Rep. 5:287-293.
39. Unoson C, Wagner EG. 2008. A small SOS-induced toxin is targeted against the inner membrane in Escherichia coli. Mol. Microbiol. 70:258-270.
40. Vázquez-Laslop N, Lee H, Neyfakh AA. 2006. Increased persistence in Escherichia coli caused by controlled expression of toxins or other unrelated proteins. J. Bacteriol. 188:3494-3497. (Pubitemid 43726213)
41. Wang X, Zhao X. 2009. Contribution of oxidative damage to antimicrobial lethality. Antimicrob. Agents Chemother. 53:1395-1402.
42. Zaslaver A, et al. 2006. A comprehensive library of fluorescent transcriptional reporters for Escherichia coli. Nat. Methods 3:623-628. (Pubitemid 44123429)
43. Zheng M, Storz G. 2000. Redox sensing by prokaryotic transcription factors. Biochem. Pharmacol. 59:1-6.